山东大学学报（医学版） ›› 2015, Vol. 53 ›› Issue (8): 11-15.doi: 10.6040/j.issn.1671-7554.0.2014.969
王琳, 吕刚, 韩亚莉, 郭晶晶, 赵群力, 何深一
WANG Lin, LÜ Gang, HAN Yali, GUO Jingjing, ZHAO Qunli, HE Shenyi
摘要： 目的 构建弓形虫棒状体蛋白7(ROP7)基因的真核重组表达载体,观察其对小鼠的免疫保护作用.方法 根据GenBank发表的弓形虫ROP7序列设计合成一对引物,通过PCR扩增ROP7基因,将其插入真核表达载体pEGFP-C1中构建重组质粒pEGFP-C1/ROP7(pROP7).用重组质粒转染HEK293T细胞并验证其在细胞内的表达.将36只雌性BALB/c小鼠随机分为3组:磷酸缓冲盐溶液(PBS)对照组、pEGFP-C1对照组和pROP7实验组.然后用PBS、pEGFP-C1和pROP7分别免疫相应组别的小鼠.采用ELISA检测小鼠血清特异IgG水平,观察弓形虫感染小鼠后的存活时间并评价其免疫保护力.结果 PCR扩增出1 728 bp的目的基因片段,真核表达载体构建成功,且能在HEK293T细胞中表达.目的基因的相应蛋白可被羊抗弓形虫多克隆抗体识别.重组质粒免疫的小鼠产生了较高水平的血清抗体.虫体攻击试验中,pROP7实验组小鼠的生存时间较对照组小鼠延长(P< 0.05).结论 本研究构建的真核表达质粒在对抗弓形虫感染时具有一定的免疫保护作用,为弓形虫基因疫苗的研制提供了参考.
中图分类号:
| [1] Schlüter D, Däubener W, Schares G, et al. Animals are key to human toxoplasmosis[J]. Int J Med Microbiol, 2014, 304(7): 917-929. [2] Xavier GA, Cademartori BG, CunhaFilho NA, et al. Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil[J]. Rev Inst Med Trop Sao Paulo, 2013, 55(1): 25-30. [3] Wallon M, Peyron F, Cornu C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years[J]. Clin Infect Dis, 2013, 56(9): 1223-1231. [4] Dubremetz JF. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction[J]. Cell Microbiol, 2007, 9(4): 841-848. [5] Taylor S, Barragan A, Su C, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii[J]. Science, 2006, 314(5806): 1776-1780. [6] 魏庆宽,王英婷,闫运琴,等. pcDNA3-HBsAg-p30-ROP2真核表达载体的构建与鉴定[J]. 中国血吸虫病防治杂志, 2014, 26(1): 46-50. WEI Qingkuan, WANG Yingting, YAN Yunqin, et al. Construction and identification of pcDNA3-HBsAg-p30-ROP2 expression vector[J]. Chinese Journal of Schistosomiasis Control, 2014, 26(1): 46-50. [7] El Hajj H, Demey E, Poncet J, et al. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling[J]. Proteomics, 2006, 6(21): 5773-5784. [8] Yuan ZG, Zhang XX, He XH, et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice[J]. Clin Vaccine Immunol, 2011, 18(1): 119-124. [9] Yuan ZG, Zhang XX, Lin R Q, et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18[J]. Vaccine, 2011, 29 (38): 6614-6619. [10] El Hajj H, Lebrun M, Fourmaux MN, et al. Inverted topology of the Toxoplasma gondii ROP5 rhoptry protein provides new insights into the association of the ROP2 protein family with the parasitophorous vacuole membrane[J]. Cell Microbiol, 2007, 9(1): 54-64. [11] Hajj HE, Lebrun M, Fourmaux MN, et al. Characterization, biosynthesis and fate of ROP7, a ROP2 related rhoptry protein of Toxoplasma gondii[J]. Mol Biochem. Parasitol, 2006, 146(1): 98-100. [12] Dzierszinski FS, Hunter CA. Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii[J]. Parasite Immunol, 2008, 30(4): 235-244. [13] Machado AV, Caetano BC, Barbosa RP, et al. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity[J]. Vaccine, 2010, 28(18): 3247-3256. [14] Zheng B, Lu S, Tong Q, et al. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice[J]. Vaccine, 2013, 31(41): 4578-4584. [15] Meng M, Zhou A, Lu G, et al. DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice[J]. BMC Infect Dis, 2013, 13: 494. doi: 10.1186/1471-2334-13-494. |
| [1] | 周剑,赵晗婷,吕刚,王琳,李启航,朱美艳,王志林,何深一. 弓形虫ROP19蛋白生物信息学分析及真核表达载体的构建[J]. 山东大学学报（医学版）, 2017, 55(3): 64-69. |
|
||
